Search alternatives:
point decrease » point increase (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
d decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
point decrease » point increase (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
d decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
16561
Flow chart of study inclusion.
Published 2023“…The intervention led to modest, but non-significant, increase in KDQOL-physical component summary scores (+3.1±1.2 points) from week 0 to week 16. There were small, non-significant decreases in interdialytic weight gain and pre-dialysis phosphorus levels in the intervention group. …”
-
16562
Baseline characteristics of the study population.
Published 2023“…The intervention led to modest, but non-significant, increase in KDQOL-physical component summary scores (+3.1±1.2 points) from week 0 to week 16. There were small, non-significant decreases in interdialytic weight gain and pre-dialysis phosphorus levels in the intervention group. …”
-
16563
-
16564
-
16565
-
16566
SS induces breast cancer cell apoptosis, G2/M checkpoint arrest, ROS accumulation and LDH-A inhibition.
Published 2013“…<p>(A) Annexin-Cy5 staining results showed that SS induced both breast cancer cells apoptosis in a dose-dependent manner; (B) JC-1 staining assay indicated that mitochondrial membrane potential was decreased after SS treatment, indicating that the mitochondrial pathway apoptosis was triggered by SS; (C) Cell cycle analysis showed that after SS treatment, the G2/M checkpoint was arrested in both breast cancer cell lines, presenting as a significant increase in G2/M subpopulations; (D) Hydroethidine was applied to detect the intracellular O<sub>2</sub><sup>−</sup> level after SS administration by flow cytometry. …”
-
16567
Mutation S223N in HA negatively affects self-elution from LAMP1 containing increased levels of α2,6 SIAs (6’LAMP1).
Published 2020“…We conclude that 6’LAMP1 contains increased levels of α2,6 SIAs and decreased levels of α2,3 SIAs. (C and D) NA-driven self-elution from 6’LAMP-coated sensors was analyzed for the indicated viruses (same stocks and amounts as used in in <a href="http://www.plospathogens.org/article/info:doi/10.1371/journal.ppat.1008816#ppat.1008816.g002" target="_blank">Fig 2</a>) as described in the legend to <a href="http://www.plospathogens.org/article/info:doi/10.1371/journal.ppat.1008816#ppat.1008816.g001" target="_blank">Fig 1</a>. …”
-
16568
-
16569
-
16570
Supplementary Material for: Behavioral Conditioning of Immune Responses with Cyclosporine A in a Murine Model of Experimental Autoimmune Uveitis
Published 2017“…<b><i>Methods:</i></b> Mice received a 0.2% w/v saccharin solution as conditioned stimulus combined with CsA (20 mg/kg) in 6 association trials at 72-h intervals. …”
-
16571
-
16572
Transcription factor c-Jun activation and cell viability in SH-SY5Y cell line following stimulation with H<sub>2</sub>O<sub>2</sub> for 3 h.
Published 2013“…Application of D-JNKI1, 30 min prior to H<sub>2</sub>O<sub>2</sub> stimulation decreased P-c-Jun activation. …”
-
16573
Possible scenarios explaining a changing Impact Factor (IF).
Published 2016“…<p>(A) Based on theoretical considerations regarding the potential influence of the variables (citations and article numbers) on the final calculation (i.e. the IF quotient), 13 scenarios are possible which either cause an increased (a1-a5), constant (b1-b3) or decreased IF (c1-c3). …”
-
16574
Summary statistics of main outcomes.
Published 2023“…To assess the difference in case management and the use of drugs across the two cases by round, a difference in difference (DiD) model was employed. …”
-
16575
Summary statistics of main outcomes by case.
Published 2023“…To assess the difference in case management and the use of drugs across the two cases by round, a difference in difference (DiD) model was employed. …”
-
16576
Standardised patient case descriptions.
Published 2023“…To assess the difference in case management and the use of drugs across the two cases by round, a difference in difference (DiD) model was employed. …”
-
16577
FIGURE 6 from D-2-HG Inhibits <i>IDH1<sup>mut</sup></i> Glioma Growth via FTO Inhibition and Resultant m6A Hypermethylation
Published 2024“…<p>ATF5 is a downstream mediator of the <i>IDH1<sup>mut</sup></i> → D-2-HG ⊣ FTO axis leading to gliomasphere growth reduction. …”
-
16578
-
16579
-
16580
Analyze data.
Published 2025“…Compared with the Sham surgery group, there was a significant decrease in NeuN over time (P < 0.01) and a significant increase in IBA-1 and CIRBP (P < 0.01) in the severe injury group. …”